Jonathan Anderman

Sr VP, Gen Counsel & Corp Sec, Compass Therapeutics, Inc.

Companies

Compass Therapeutics, Inc.General counsel Jan 5, 2026 to now¹
Compass Therapeutics, Inc.Sr VP, Gen Counsel & Corp Sec Aug 9, 2024 to now²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Compass Therapeutics, Inc. CMPX196,000 shares³$168.6K at $0.86Apr 29, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Apr 29, 2026Bought 25,000 shares at $1.89 of Compass Therapeutics, Inc.³
Apr 29, 2026Granted 25,000 shares at $1.89 of Compass Therapeutics, Inc.⁴
Jan 2, 2026Granted 150,000 shares at $5.17 of Compass Therapeutics, Inc.⁵
Apr 7, 2025Bought 20,000 shares at $1.54 of Compass Therapeutics, Inc.⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARCompass Therapeutics, Inc., General counsel
2
SEC EDGARCompass Therapeutics, Inc., Sr VP, Gen Counsel & Corp Sec
3
SEC EDGARCompass Therapeutics, Inc. shares after the filing of Apr 29, 2026
4
SEC EDGARForm 4 filed Apr 29, 2026
5
SEC EDGARForm 4 filed Jan 5, 2026
6
SEC EDGARForm 4 filed Apr 8, 2025